Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Platelet Rich Plasma (PRP) injections can improve hair count, thickness, and strength in people with androgenic alopecia.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Some women with PCOS have rare genetic variants linked to the condition.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Provenge extends prostate cancer survival by about 4 months.

AMPK activation may reduce melanoma risk in red-haired individuals.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

PCA patients have more harmful bacteria and antibiotic resistance, needing specific testing for treatment.

Platelet Rich Plasma (PRP) therapy can improve hair thinning in male pattern baldness patients, but more research is needed to confirm its effectiveness.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

ILC1-like cells can cause alopecia areata by themselves.

CRABP1 boosts hair cell growth in Hu sheep by affecting key genes.

The document's conclusion cannot be provided because the content is not available.

Platelet-rich plasma treatments help hair growth in people with hair loss by increasing certain cell growth and protein levels.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Machine learning can accurately predict Polycystic Ovary Syndrome in women using clinical features.

Potential new drugs for treating PCOS were identified.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

CRABP2 helps increase the growth of cells important for hair growth by activating a specific growth pathway.

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The PI's development is closely linked to skin and hair pigmentation in macaques.

ePUKs could be valuable for regenerative medicine due to their wound healing abilities.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

Patched1 helps prevent tumors by controlling cell growth.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

Analog 23 is a promising compound for prostate cancer treatment.